Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose-response Relationship of Five Dose Levels of NNC90-1170 and Placebo on Glycaemic Control in Type 2 Diabetic Patients Compared to OHA Treatment. A 12-week Multi-centre, Double-blind, Randomised, Parallel Group Trial With an Open Labelled OHA Arm

NCT01509755 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01509755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01509755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose-response Relationship of Five Dose Levels of NNC90-1170 and Placebo on Glycaemic Control in Type 2 Diabetic Patients Compared to OHA Treatment. A 12-week Multi-centre, Double-blind, Randomised, Parallel Group Trial With an Open Labelled OHA Arm
Lead sponsor
Novo Nordisk A/S
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2000
Completion date
October 31, 2001
Enrollment
196 (estimated)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2